Drug intelligence / Profile preview

diclofenac + metaxalone

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Diclofenac + metaxalone is a **combination medication** used to treat pain and muscle spasms associated with musculoskeletal conditions. The formulation combines **diclofenac potassium (50 mg)**, a nonsteroidal anti-inflammatory drug (NSAID), with **metaxalone (400 mg)**, a muscle relaxant. **Mechanism of Action:** - **Diclofenac** works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby blocking prostaglandin synthesis, which reduces pain, inflammation, and swelling - **Metaxalone** acts on the central nervous system, specifically on centers in the brain and spinal cord, to reduce muscle spasms and stiffness, though its exact mechanism remains unclear This combination provides dual action by targeting both the inflammatory component and muscular tension simultaneously, making it particularly effective for conditions like acute musculoskeletal pain, back pain, strains, sprains, muscle injuries, gout, joint pain, osteoarthritis, ankylosing spondylitis, and rheumatoid arthritis. The medication improves mobility and flexibility while providing quick relief from acute pain.

Brand names
TEPRO-MXFlexodic-MFlexura DMobiswift-DMyospaz DLysoflam-MRDolserKudzu FlexFlexalone DSpitax DMetapain-DMobibert DFlexilong DStayHappi Diclofenac+Metaxalone
Other names
diclofenac potassium + metaxalone
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on diclofenac + metaxalone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac + metaxalone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call